GeneFerm Biotechnology Co., Ltd. (TPEX:1796)

GeneFerm Biotechnology Revenue

GeneFerm Biotechnology had revenue of 165.60M TWD in the quarter ending September 30, 2025, with 25.57% growth. This brings the company's revenue in the last twelve months to 654.88M, up 19.26% year-over-year. In the year 2024, GeneFerm Biotechnology had annual revenue of 521.16M, down -34.34%.

• Revenue (ttm): 654.88M
• Revenue Growth: +19.26%
• P/S Ratio: 2.84
• Revenue / Employee: 4.55M
• Employees: 144
• Market Cap: 1.86B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	521.16M	-272.61M	-34.34%
Dec 31, 2023	793.77M	159.81M	25.21%
Dec 31, 2022	633.96M	111.63M	21.37%
Dec 31, 2021	522.33M	154.03M	41.82%
Dec 31, 2020	368.30M	40.07M	12.21%